Indication
Nosocomial bacterial pneumonia
Nosocomial bacterial pneumonia is an acute infection of the lower respiratory tract parenchymal tissue acquired in an inpatient healthcare setting, typically defined by the onset of symptoms 48 hours or more following hospital admission that were not incubating upon entry. Read more about Nosocomial bacterial pneumonia
72 drugs 49 manufacturers
Drugs that treat it
Common Nosocomial bacterial pneumonia therapies.
TOBRAMYCIN SULFATE
AMIKACIN SULFATE
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
AVYCAZ (ceftazidime/avibactam sodium)
TOBRAMYCIN SULFATE IN NS (tobramycin sulfate/sodium chloride)
PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium)
ZOSYN (piperacillin sodium/tazobactam sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonNosocomial bacterial pneumonia is an acute infection of the lower respiratory tract parenchymal tissue acquired in an inpatient healthcare setting, typically defined by the onset of symptoms 48 hours or more following hospital admission that were not incubating upon entry.
It primarily affects hospitalized individuals, particularly critically ill, elderly, immunocompromised, or mechanically ventilated patients.
Pathophysiologically, the condition commonly arises when colonized pathogenic bacteria—frequently multidrug-resistant Gram-negative bacilli such as *Pseudomonas aeruginosa* or Gram-positive cocci such as *Staphylococcus aureus*—are microaspirated from the oropharynx into the pulmonary alveoli, overwhelming host immune defenses.
Clinically, it presents with new or progressive pulmonary infiltrates on chest imaging accompanied by systemic and respiratory features, including fever, leukocytosis or leukopenia, purulent sputum production, and worsening hypoxemia.
- nih.gov
Nosocomial bacterial pneumonia is an acute infection of the lower respiratory tract parenchymal tissue acquired in an inpatient healthcare setting, typically defined by the onset of symptoms 48 hours or more following hospital admission that were not incubating upon entry It primarily affects hospitalized individuals, particularly critically ill, elderly, immunocompromised, or mechanically ventilated patients
- nih.gov
Nosocomial bacterial pneumonia is an acute infection of the lower respiratory tract parenchymal tissue acquired in an inpatient healthcare setting, typically defined by the onset of symptoms 48 hours or more following hospital admission that were not incubating upon entry
- litfl.com
It primarily affects hospitalized individuals, particularly critically ill, elderly, immunocompromised, or mechanically ventilated patients Pathophysiologically, the condition commonly arises when colonized pathogenic bacteria—frequently multidrug-resistant Gram-negative bacilli such as *Pseudomonas aeruginosa* or Gram-positive cocci such as *Staphylococcus aureus*—are microaspirated from the oropharynx into the pulmonary alveoli, overwhelming host immune defenses Clinically, it presents with ne...
- columbiadoctors.org
It primarily affects hospitalized individuals, particularly critically ill, elderly, immunocompromised, or mechanically ventilated patients Clinically, it presents with new or progressive pulmonary infiltrates on chest imaging accompanied by systemic and respiratory features, including fever, leukocytosis or leukopenia, purulent sputum production, and worsening hypoxemia
- mdsearchlight.com
Pathophysiologically, the condition commonly arises when colonized pathogenic bacteria—frequently multidrug-resistant Gram-negative bacilli such as *Pseudomonas aeruginosa* or Gram-positive cocci such as *Staphylococcus aureus*—are microaspirated from the oropharynx into the pulmonary alveoli, overwhelming host immune defenses
- nih.gov
Pathophysiologically, the condition commonly arises when colonized pathogenic bacteria—frequently multidrug-resistant Gram-negative bacilli such as *Pseudomonas aeruginosa* or Gram-positive cocci such as *Staphylococcus aureus*—are microaspirated from the oropharynx into the pulmonary alveoli, overwhelming host immune defenses
- nih.gov
Clinically, it presents with new or progressive pulmonary infiltrates on chest imaging accompanied by systemic and respiratory features, including fever, leukocytosis or leukopenia, purulent sputum production, and worsening hypoxemia
Personalize your experience
Follow Nosocomial bacterial pneumonia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.